Schonfeld Strategic Advisors »

Vyne Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $317k 169k 1.88
2024-06-30 $426k 216k 1.97
2024-03-31 $675k 220k 3.07

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Msci Emg Mkt Etf (EEM)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Spotify Technology S A SHS (SPOT)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
salesforce (CRM)

View all positions for Schonfeld Strategic Advisors

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
DSC Advisors
Silverarc Capital Management
Palo Alto Investors
Vanguard Group
Exome Asset Management
Parkman Healthcare Partners
AlphaCentric Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Renaissance Technologies
BlackRock
BlackRock

View all funds holding Vyne Therapeutics